MedPath

Century Therapeutics

Century Therapeutics logo
🇺🇸United States
Ownership
Public
Established
2018-01-01
Employees
165
Market Cap
-
Website
http://www.centurytx.com
Introduction

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Phase 1
Recruiting
Conditions
Systemic Lupus Erythematosus
Lupus Nephritis
Idiopathic Inflammatory Myopathies
Diffuse Cutaneous Systemic Sclerosis
Interventions
Drug: Lymphodepleting Chemotherapy
First Posted Date
2024-02-12
Last Posted Date
2025-04-04
Lead Sponsor
Century Therapeutics, Inc.
Target Recruit Count
48
Registration Number
NCT06255028
Locations
🇺🇸

Keck School of Medicine of University of Southern California, Los Angeles, California, United States

🇺🇸

UC Davis, Sacramento, California, United States

🇺🇸

Lurie Children's; Northwestern Medicine - Northwestern Medical Group, Chicago, Illinois, United States

and more 2 locations

A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Recruiting
Conditions
Hematological Malignancy
Solid Tumor Malignancy
Interventions
Other: No Intervention
First Posted Date
2023-03-14
Last Posted Date
2025-02-28
Lead Sponsor
Century Therapeutics, Inc.
Target Recruit Count
375
Registration Number
NCT05768269
Locations
🇺🇸

University of Southern California - Norris Comprehensive Cancer Center, Los Angeles, California, United States

🇺🇸

Banner MD Anderson Cancer Center, Gilbert, Arizona, United States

🇺🇸

University of Maryland Medical Center, Baltimore, Maryland, United States

and more 4 locations

A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies

Phase 1
Active, not recruiting
Conditions
Aggressive Non-Hodgkin Lymphoma
Indolent Non-Hodgkin Lymphoma
R/R CD19-Positive B-Cell Malignancies
Interventions
Drug: Lymphodepleting Chemotherapy
First Posted Date
2022-04-20
Last Posted Date
2025-04-13
Lead Sponsor
Century Therapeutics, Inc.
Target Recruit Count
28
Registration Number
NCT05336409
Locations
🇺🇸

Banner MD Anderson Cancer Center, Gilbert, Arizona, United States

🇺🇸

University of Southern California - Norris Comprehensive Cancer Center, Los Angeles, California, United States

🇺🇸

University of California San Diego, Moores Cancer Center, San Diego, California, United States

and more 13 locations
© Copyright 2025. All Rights Reserved by MedPath